G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer
pharmaceutical investing Adaptimmune Reports Fourth Quarter / Full Year 2017 Financial Results and Business Update
pharmaceutical investing Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
Heat Biologics Presents Immune Data on its HS-410 Phase 2 Bladder Cancer Trial at the Genitourinary Cancers Symposium
Canadian Gold Resources to Expand Maiden Diamond Drill Program & Provides Update on Bulk Sampling Program at Lac Arsenault, LIFE Offering Update; Disclosure Corrections
Emerita Intersects 9.6 Meters Grading 2.7% Copper, 1.85 g/t Gold and 6.9 Meters Grading 1.4% Copper, 1.85 g/t Gold at El Cura Deposit
